HISTORY

Discovery of the molecular code for redox-related signaling

1999

Initiation of molecular modeling

against BRD4 target molecule

2012

•MSA with Wuxi Apptec Contract

•Patent Filing

•Established Epigenetics Research Institute

  (R&D Center)

•KWB-BR01, -02, -03, -04 P.O.C. Studies

•Preclinical Test

2019
2005

Identification of redox model including

Identification of anti-cancer & anti-inflammatory mechanism

2018

•Completed four BRD4 target molecular 

  modeling

•BenoBio Co., Ltd. established

•Collaboration with the Catholic University

  of Korea Hospital

•Drug Delivery System

  technology  Contract with Germany

•Contract with the Catholic University of

  Korea

© BenoBio Co., Ltd.

  • Facebook
  • Twitter
  • YouTube
  • 회색 링크드 인 아이콘